Guizhi (Cinnamomum cassia twig)
Guizhi, the dried twig of Cinnamomum cassia, contains cinnamaldehyde and cinnamic acid as its primary bioactive compounds, which modulate inflammatory pathways and peripheral circulation. In Traditional Chinese Medicine, it is classified as acrid and warm, used to release the exterior and warm the channels by harmonizing Ying and Wei Qi.

Origin & History
Guizhi, scientifically known as Cinnamomum cassia twig, is derived from the young shoots of the Cinnamomum cassia tree, native to Southeast Asia including China and Vietnam. It is processed into powder, liquid extracts, or essential oil through drying and distillation methods.
Historical & Cultural Context
In Traditional Chinese Medicine, Guizhi has been used for over 2,000 years to treat colds, fever, and chills by warming and releasing the exterior. It is believed to enter the Heart, Lung, and Bladder channels, addressing symptoms like cough and menstrual irregularities.
Health Benefits
• Supports respiratory health and relieves cold symptoms, as traditionally used in TCM, though no human clinical evidence supports this. • Believed to help balance Ying and Wei Qi to combat wind-cold invasions, based on traditional usage. • May have anti-inflammatory properties due to volatile compounds like cinnamaldehyde, but lacks human study confirmation. • Could enhance circulation and relieve muscle pain, as per historical applications, without clinical backing. • Potentially aids in menstrual irregularities through its warming effect, according to TCM practices.
How It Works
Cinnamaldehyde, the principal volatile constituent of Guizhi, inhibits NF-κB signaling and suppresses COX-2 enzyme activity, reducing pro-inflammatory cytokine production including TNF-α and IL-6. Cinnamic acid and its derivatives act as transient receptor potential (TRP) channel modulators, particularly TRPA1, which may explain the warming and vasodilatory sensations associated with its use. Additionally, procyanidins present in the twig fraction have demonstrated inhibition of thromboxane A2 synthesis, potentially contributing to its traditional use in promoting blood circulation.
Scientific Research
No specific human clinical trials, RCTs, or meta-analyses for Guizhi alone were found. A patent describes animal model studies with cassia twig compositions, but there is no human data or PMIDs available.
Clinical Summary
Human clinical evidence specifically for Guizhi twigs is sparse; most available data derives from in vitro studies and animal models examining cinnamaldehyde and related phenolic compounds. A small number of studies on Guizhi Tang (a classical TCM formula containing Guizhi) in populations with common cold or influenza symptoms suggest modest symptomatic relief, though these trials typically involve fewer than 100 participants and lack rigorous blinding. Preclinical rodent studies demonstrate anti-inflammatory and antipyretic effects at doses of 50–200 mg/kg of Guizhi extract, but direct human dose-equivalent translation remains unestablished. Overall, the evidence base is preliminary and insufficient to support definitive clinical claims without larger, controlled human trials.
Nutritional Profile
Guizhi (Cinnamomum cassia twig) is used in small medicinal doses (3–9g dried twig per decoction) rather than as a food, so macronutrient contribution is negligible. Key bioactive compounds include: Volatile oils (1–2% of dry weight), dominated by trans-cinnamaldehyde (60–75% of the essential oil fraction), which is the primary pharmacologically active constituent. Other volatile components include cinnamyl acetate (~3–5%), eugenol (~1–2%), β-caryophyllene (~2–4%), and linalool (trace amounts). Phenolic compounds are present, including cinnamic acid derivatives and coumarin (approximately 0.45–0.95mg/g dry weight — notably higher in cassia-derived material than Ceylon cinnamon, warranting caution with high-dose long-term use due to hepatotoxic potential of coumarin). Procyanidin-type polyphenols and flavonoids are present in modest amounts, contributing to antioxidant activity (ORAC values broadly comparable to other cinnamon materials, estimated 1,000–3,000 µmol TE/100g dry weight for bark/twig material). Diterpenes including cinnzeylanol and cinnzeylanine have been identified in small quantities. Mineral content includes trace manganese, calcium, and iron, though amounts delivered per standard decoction dose are pharmacologically insignificant. Carbohydrates (primarily cellulose, hemicellulose, and starch) constitute the bulk dry mass (~60–70%) but are largely insoluble and not bioavailable via decoction. Bioavailability note: Aqueous decoction extracts cinnamaldehyde and water-soluble polyphenols efficiently; cinnamaldehyde is rapidly absorbed but also rapidly metabolized to cinnamic acid in vivo, with peak plasma levels within 30–60 minutes. Coumarin is water-soluble and readily extracted into decoctions, making intake monitoring relevant for chronic use.
Preparation & Dosage
There are no clinically studied dosage ranges for Guizhi due to the absence of human trials. Commercial products contain dried twig powder and liquid extracts, but lack standardization details. Essential oils are for topical use only. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Poria cocos, ginger, licorice root, peony root, angelica sinensis
Safety & Interactions
Guizhi is generally considered safe at culinary and low supplemental doses, but high doses of cinnamaldehyde may cause gastrointestinal irritation, mouth sores, or allergic contact dermatitis in sensitive individuals. It should be used with caution alongside anticoagulant medications such as warfarin, as its thromboxane-inhibiting properties may potentiate bleeding risk. Guizhi is contraindicated in TCM practice for individuals with heat-excess patterns, presenting with fever from wind-heat invasion, or spontaneous sweating without cold exposure, and is traditionally avoided during pregnancy due to its warming, blood-moving properties. Patients on antidiabetic drugs should also exercise caution, as cinnamon-related compounds can have mild hypoglycemic effects that may alter blood glucose management.